Radiation therapy for @entity66 in XXXX .

@entity1 @entity320 @entity66
Radiation therapy has been widely used for palliative management of inoperable metastatic @entity320 . For @entity1 with @entity66 , response rates of approximately 70% have been reported. There are limited data concerning the role of adjuvant irradiation following therapeutic lymph node dissection. In this review, 57 @entity1 with isolated resectable and nonresectable @entity66 have been treated with radiation. The overall response rate is 84% for bulky disease. Large fractions are beneficial. The median disease-free survivals were 11 months after adjuvant treatment and 7 months for those with inoperable disease. The median overall survivals were 20 months and 18 months, respectively. Local control in long-term survivors was excellent. Sixty-five percent of @entity1 developed distant metastases. There is a need for additional studies with the use of adjuvant radiation therapy following lymph node dissection.
